APA (7th ed.) Citation

Jbara-Agbaria, D., Blondzik, S., Burger-Kentischer, A., Agbaria, M., Nordling-David, M. M., Giterman, A., . . . Golomb, G. (2022). Liposomal siRNA Formulations for the Treatment of Herpes Simplex Virus-1: In Vitro Characterization of Physicochemical Properties and Activity, and In Vivo Biodistribution and Toxicity Studies. Pharmaceutics, 14(3), 633. https://doi.org/10.3390/pharmaceutics14030633

Chicago Style (17th ed.) Citation

Jbara-Agbaria, Doaa, Saskia Blondzik, Anke Burger-Kentischer, Majd Agbaria, Mirjam M. Nordling-David, Anna Giterman, Gil Aizik, Steffen Rupp, and Gershon Golomb. "Liposomal SiRNA Formulations for the Treatment of Herpes Simplex Virus-1: In Vitro Characterization of Physicochemical Properties and Activity, and In Vivo Biodistribution and Toxicity Studies." Pharmaceutics 14, no. 3 (2022): 633. https://doi.org/10.3390/pharmaceutics14030633.

MLA (9th ed.) Citation

Jbara-Agbaria, Doaa, et al. "Liposomal SiRNA Formulations for the Treatment of Herpes Simplex Virus-1: In Vitro Characterization of Physicochemical Properties and Activity, and In Vivo Biodistribution and Toxicity Studies." Pharmaceutics, vol. 14, no. 3, 2022, p. 633, https://doi.org/10.3390/pharmaceutics14030633.